NCT00926224View on ClinicalTrials.gov

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

September 30, 2010

Conditions
Liver FibrosisCirrhosis
Interventions
DEVICE

FibroScan M and XL probes

Each patient undergo two liver stiffness measurements with the FibroScan: once with the M probe and once with the XL probe

Trial Locations (5)

T2N 4N

Calgary University Hospital, Calgary

N6A 5A5

London University Hospital, London

M5T 2S8

Toronto Western General Hospital, Toronto

M6H 3M1

Toronto Liver Centre, Toronto

H2X 3J4

Saint-Luc University, Montreal

Sponsors

Lead Sponsor

Echosens
All Listed Sponsors
lead

Echosens

INDUSTRY

NCT00926224 - Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients | Biotech Hunter | Biotech Hunter